Navigation Links
Perfluoron Liquid

ProductsPerfluoron Liquid
Company Alcon Laboratories
Item Perfluoron Liquid
Features 
  • Certified to be > 99.9 percent pure - the purest perfluorocarbon available.
  • Lowest possible refractive index and low viscosity, making it easy to identify and remove.
  • Highest vapor pressure, to aid in the removal of residual material.
  • Provides gentle traction.
  • High specific gravity, which displaces subretinal fluids for complete retinal flattening and reduction of posterior retinotomy.
  • Optical clarity, eliminating optical reflexes encountered when dissecting under oil.
Description Welcome to a new dimension in vitreoretinal surgery. By using Perfluoron, a liquid tool composed of purified perfluoro-n-octane, you can greatly expand your surgical capabilities. Perfluoron is ideal for managing retinal detachments complicated by proliferative vitreoretinopathy, giant retinal tears and trauma.

Certified to be >99.9 percent pure, Perfluoron is the purest perfluorocarbon available. The purity of cyclic chain perfluorocarbons such as perfluorodecalin (about 95 percent pure) and perfluorophenanthrene cannot be accurately verified because they generate multiple peaks in gas liquid chromatography and nuclear magnetic resonance spectroscopic analysis. However, Perfluoron has a straight chain, which generates a single peak so its purity can be accurately analyzed.

Perfluorons properties make your procedure more efficient, with less risk of subretinal fluids, reducing the need for posterior retinotomy. With the lowest possible refractive index of any other liquid perfluorocarbon, you can easily differentiate Perfluoron from irrigating fluids it does not mix with water, ionic solutions or common organic chemicals. Perfluorons low viscosity causes it to form droplets rather than to spread, making it easy to find and remove. It also has the highest vapor pressure to facilitate removal.

Another advantage of Perfluoron is its optical clarity, which gives you an unobstructed view of retinal structures. Because Perfluoron is optically clear, it also eliminates the optical reflexes encountered when you dissect under oil.

Due to Perfluorons high specific gravity, its tamponading effect is greater than silicone oil to give you unparalleled control. Perfluoron becomes a hydrokinetic tool for opening a funneled retinal detachment in proliferative vitreoretinopathy. It also becomes a third hand for stabilizing the retina for peeling or delamination of epiretinal membranes. Perfluoron provides gentle traction on epiretinal membranes for more precise, efficient procedures.

In addition, the high specific gravity of Perfluoron displaces subretinal fluids so the retina flattens completely. Perfluoron is also ideal for laser surgery because it does not absorb visible light and has a higher boiling point (105C) than irrigating fluid.

Info Alcon Laboratories
Customer Service: (800) 757-9195
Web site: http://www.alconlabs.com/

Related medicine products :

1. BUN Liquidplus Reagent
2. Urea Nitrogen (BUN) Liquid Reagent
3. ALT (GPT) Liquidplus Reagent
4. ALT (SGPT) Liquid Reagent (Kinetic Method)
5. g-GT Liquid Reagent
6. Gama-GT Liquid Reagent
7. Inorganic Phosphorus (Liquid)
8. Glucose Color Liquidplus Reagent
9. Glucose UV Liquidplus
10. Glucose Hexokinase Liquid
11. Glucose (Liquid) Reagent
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products:
(Date:5/29/2015)... Displays and Exhibits’ has recently aligned with a new hanging ... signs ; making what was formerly an elite expensive ... points at a usual height of 16’-20’ are easily seen ... are very unique and more visible than the largest exhibits. ... labor and rigging the costs far outweigh the benefit of ...
(Date:5/29/2015)... 2015 Based in St. Louis, Missouri La ... for a couple of months now and are really ... which reads “I’m not misbehaving, I have Autism, please be ... of an autistic child in order to start a conversation ... only are they raising awareness through the autism awareness shirts ...
(Date:5/29/2015)... What does community do? , According to ... together to plant gardens, to teach young people, to ... critical issues. Community invites everyone to help improve lives ... Community Does" was commissioned by The Denver Foundation, the ... during the foundation’s Annual Celebration in May. At just ...
(Date:5/29/2015)... May 29, 2015 M3 USA MDLinx.com, ... in 14 medical specialties, now offers The Smartest ... spectrum of rheumatology disorders ranging from Fibromyalgia and Osteoporosis, ... editorial director of MDLinx, and Caroline Tredway, editorial head ... impact it will have on the physicians who participate. ...
(Date:5/29/2015)... Cincinnati, Ohio (PRWEB) May 29, 2015 ... Proven Experience to Cincinnati , The Department of Veterans ... John A. Gennaro as the new director of the ... of health care to more than 43,000 unique Veterans ... , With over 2,000 staff, CVAMC is a two-division ...
Breaking Medicine News(10 mins):Health News:Displays and Exhibits Announces New Hanging Sign Supplier 2Health News:La La Land Shirts Is Busy Spreading Autism Awareness with Complimentary Shipping on Their New Shirt 2Health News:What Community Does: A New Video from The Denver Foundation 2Health News:MDLinx Launches Smartest Rheumatologist 2Health News:VA Healthcare System of Ohio Network Announces New Medical Center Director 2
... ... promotes Prize4Life. , ... (Vocus) March 24, 2010 -- In April of 2009, Director/Producer James Takata, Writers/Producers Zach ... Prize4Life’s battle against ALS. Trapped is a short film about Stephen, a talented young ...
... in Spanish . Barcelona, Spain: Recurrence ... tumour remains the strongest, independent prognostic factor for subsequent metastasis ... disease for a very long time, according to research presented ... Dr Sven Mieog, MD, a research fellow at Leiden ...
... release is available in Spanish . ... women are surviving breast cancer and delaying childbirth, it is ... fertility into consideration when deciding on treatment, the seventh European ... Dr. Anne Armstrong, from the Department of Medical Oncology, the ...
... after the death of a loved one can provide much-needed ... a study in the April issue of the Journal ... lost a relative to cancer took part in the study. ... included widows, widowers, daughters and sisters. Nine chose foot massage, ...
... Organic Relaxation Herbal ... the product works. This Herbal Tea can be purchased at Youmeandtea.com, , , ... (PRWEB) March 24, 2010 -- Organic Relaxation ... well the product works. This Herbal Tea can be purchased at Youmeandtea.com , ,"I ...
... ... obesity and empower kids to make healthy decisions. , ... (Vocus) March 24, 2010 -- To help kids to make healthy ... www.mvpkidpower.com on Facebook., , , , ,“Being on Facebook enables KidPower to actually ...
Cached Medicine News:Health News:Prize4Life Inspires Award-winning ALS Film: Trapped 2Health News:Prize4Life Inspires Award-winning ALS Film: Trapped 3Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 2Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 3Health News:Fertility issues in young women with breast cancer must be addressed 2Health News:Hand and feet massages provide consolation for bereaved relatives 2Health News:Snoring Reduced With Relaxation Tea… Could It Be? 2Health News:Snoring Reduced With Relaxation Tea… Could It Be? 3Health News:MVP Health Care Takes KidPower Youth Sports Program to Facebook 2
(Date:5/30/2015)... 30, 2015  Astellas Pharma Inc. (TSE: 4503) today ... on the safety, tolerability and efficacy of ASP2215, a ... refractory (R/R) acute myeloid leukemia (AML) were presented during ... Clinical Oncology,s (ASCO) annual meeting in Chicago ... kinase inhibitor of FLT3 and AXL, which are involved ...
(Date:5/30/2015)... Wash. and VANCOUVER, British Columbia ... Inc. (NASDAQ: OGXI ) announced today that results ... trial showed a benefit with custirsen therapy in men ... poor prognosis. The analysis, exploring the effect of clusterin ... that over 40 percent of men in the trial ...
(Date:5/30/2015)... y SPARTANBURG , Carolina ... - Nueva colaboración para ampliar drásticamente ... con cáncer en los Estados Unidos   ... Health proporcionarán a los pacientes con cáncer apoyo ... Guardian Research Network y Molecular Health han anunciado ...
Breaking Medicine Technology:Astellas Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML) 2Astellas Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML) 3OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 2OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 3OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 4OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 5OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 6Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 2Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 3Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 4